J. Deemer’s research while affiliated with Gracie Square Hospital, New York, NY and other places

... Many patients and healthcare professionals (HCPs) are hesitant to use liver biopsies due to costs and associated risks [16]. The requirement for liver biopsy to confirm diagnosis could be contributing to the under-diagnosis of NASH; liver biopsies are potentially dangerous, resource-intensive, and have limited scalability [17]. The field is looking to non-invasive tests (NITs) to identify those at most risk, who can then be targeted for therapy or more confidently exclude those who do not need specialty care [18]. ...

Reference:

Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey